Press release -

Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden

On the 28th of October 2016, ConceptoMed and AB Euroform MediPharm entered into an agreement for high-volume capacity manufacturing for Luer-Jack. Euroform MediPharm is a ISO 13485 certified long-term partner within development and production of polymer products for world class customers in Pharmaceutical and Medical Technology industries. Euroform MediPharm operates a medical plant Cleanroom class 8 facilities in Motala, Sweden. AB Euroform also operates high-tech industrial injection molding plants in Motala and Tranås in Sweden.

Wind will power the manufacturing of Luer-Jack

AB Euroform is owned by Vätterleden Invest, which among other businesses, also owns and operates a wind-mill plant in the southern part of Sweden. The Vätterleden owned wind-power plant produces more electrical power than the total aggregate power consumption for all manufacturing operations in AB Euroform.


‘AB Euroform MediPharm have supported the early phase manufacturing for Luer-Jack. I am very pleased to focus on our growth phase together with a great company and great people from Sweden. The agreement with AB Euroform MediPharm enables ConceptoMed to secure deliveries to a growing customer base for Luer-Jack. It is an important milestone for ConceptoMed, for the global growth of the Luer-Jack concept - and ultimately for patients and healthcare workers worldwide – also beyond Europe’, said Christian Mide, M.D., CEO and founder of ConceptoMed.

‘It is very exciting to continue a fruitful cooperation with the innovative team of ConceptoMed. Now we are thrilled to take our cooperation into high volume production and an even closer cooperation‘, said Håkan Jimstad, CEO and partner of AB Euroform.



ConceptoMed AS is a ISO 13485 certified, ambitions medtech company serving the global market with innovative product categories and unique proprietary technology. We create smart medtech systems that empower healthcare professionals and improve patient care. Excellence through simplicity is our code. We are brave, curious and dedicated. We simply care.

Based in Norway, the team is continuously meeting milestones and expanding its activities for international growth. For more information on the company and career opportunities, see www.conceptomed.com and www.luerjack.com. Follow us on MyNewsdesk and LinkedIn.

Euroform MediPharm is a ISO 13485 certified Swedish long-term partner within development and production of polymer products for world class customers in Pharmaceutical and Medical Technology industries. Many years of experience within highly qualified polymer system solutions development has formed the solid base of peak competence and quality awareness that is seen in everything we do today.

Luer-Jack® is a registered trademark owned by ConceptoMed AS. The Luer-Jack® technology is widely patent protected throughout the world, currently with almost 50 patents (granted and pending) from 8 patent families.

Related links

Topics

  • Business enterprise

Contacts

Related media

  • Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden
    Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden
    License:
    Media Use
    File format:
    .pdf
    more info...
    Download
  • Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden
    License:
    Media Use
    File format:
    .docx
    more info...
    Download

Related content

  • ConceptoMed obtains ISO 13485 certification

    ConceptoMed is proud to announce that it successfully passed the ISO 13485 quality assurance audit, and was issued the international ISO 13485 certificate by SP, our Notified Body.

  • European and Australian Patent Issued for Luer-Jack

    On the 31st of August 2016, the European Patent Office issued an official document granting the European patent for Luer-Jack. IP Australia, the Australian Government agency that administers intellectual property (IP) rights and legislation relating to patents, issued an official document granting the Australian patent for Luer-Jack - also on the 31st of August 2016.

  • ConceptoMed named in Disrupt 100 - Index of Disruptive Businesses Worldwide

    ConceptoMed proudly announce being named in the Disrupt 100 - a bi-annual Tällt Ventures publication celebrating the businesses with the most potential to influence, change or create new global markets. ConceptoMed were selected from over 1 million global startups and corporate ventures and judged by a selection of global brands.

  • US Patent issued for Luer-Jack®

    On the 10th of May 2016, the United States Patent and Trademark office issued an official document granting the US patent for Luer-Jack. The US Luer-Jack patent is an important part of the families of similar filed applications in all important markets world wide, and is a fundamental member of the Luer-Jack patent family.

  • Luer-Jack secures Sterigenics Sterilization Services Agreement

    In December 2016, ConceptoMed have entered into important collaborations with suppliers of sterilization services (Sterigenics) and logistics & healthcare warehousing services (DSV Logistics) to secure the global strategy for ConceptoMed and Luer-Jack.

  • ConceptoMed named "Company of the Year 2016" of Norwegian Medtech Cluster

    On Thursday 8th of December 2016, ConceptoMed was named Company of the Year 2016 among approx 190 members of Oslo Medtech, a health technology cluster dedicated to accelerate and support the development of new medtech and eHealth products, services and innovative solutions for the Norwegian and global health care market.

Enter your email address to follow ConceptoMed

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow ConceptoMed.

Okay